what I interpreted from the round table discussion with the pharmaceutical and biotech companies was that the discussion had the potential to be related to therapeutic treatments, vaccines and cures in general
-
expediting processes
-
maximum speed to develop treatments
-
manufacturing in America
-
congressional (governmental) support
the Corona outbreak would then be playing in favor of getting cures quickly out for the public, as planned, without the expected obstruction of the DS